)
Immunovant (IMVT) investor relations material
Immunovant Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for September 2, 2026, with virtual participation available.
Shareholders are invited to vote on key proposals, including director elections, auditor ratification, and executive compensation.
Voting matters and shareholder proposals
Election of three directors to serve until the 2027 annual meeting: Jacob Bauer, Douglas Hughes, and Robert Susman.
Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending March 31, 2027.
Advisory vote on executive compensation for named executive officers.
Proxy holders may vote on other business arising at the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all three director nominees.
Directors to serve one-year terms, subject to re-election at the next annual meeting.
- Proxy covers director elections, auditor ratification, and executive pay, emphasizing governance.IMVT
Proxy filing22 Jul 2026 - IMVT-1402 achieved high response rates in uncontrolled Graves', with pivotal trial set for year-end.IMVT
Status Update9 Jul 2026 - Five INDs cleared for IMVT-1402, with $472.9M cash and pivotal trials imminent.IMVT
Q2 20255 Jul 2026 - Brepocitinib advances in LPP as batoclimab's TED phase 3 informs Graves' disease focus.IMVT
Study result1 Jul 2026 - Batoclimab achieved durable ATD-free remission in uncontrolled Graves' disease, with pivotal trials ongoing.IMVT
Study update presentation24 Jun 2026 - Strong D2T RA efficacy and pipeline momentum drive focus on IMVT-1402 and upcoming launches.IMVT
Q4 202622 May 2026 - IMVT-1402 targets major autoimmune diseases with best-in-class efficacy and broad market reach.IMVT
Corporate presentation20 May 2026 - Robust phase 2 results and $994.5M cash position drive pipeline and clinical trial momentum.IMVT
Q3 202613 Apr 2026 - IMVT-1402 targets major autoimmune diseases with best-in-class efficacy and broad market reach.IMVT
Corporate presentation13 Feb 2026
Next Immunovant earnings date
Next Immunovant earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)